Order Article Reprints

Zhou X, Zhu Z, Kuang S, Huang K, Li Y, Wang Y, Chen H, Hoi MPM, Xu B, Yang X, et al. Tetramethylpyrazine Nitrone (TBN) Reduces Amyloid β Deposition in Alzheimer’s Disease Models by Modulating APP Expression, BACE1 Activity, and Autophagy Pathways. Pharmaceuticals. 2024; 17(8):1005. https://doi.org/10.3390/ph17081005

Zhou, Xinhua, Zeyu Zhu, Shaoming Kuang, Kaipeng Huang, Yueping Li, Yuqiang Wang, Haiyun Chen, Maggie Pui Man Hoi, Benhong Xu, Xifei Yang, and et al. 2024. "Tetramethylpyrazine Nitrone (TBN) Reduces Amyloid β Deposition in Alzheimer’s Disease Models by Modulating APP Expression, BACE1 Activity, and Autophagy Pathways" Pharmaceuticals 17, no. 8: 1005. https://doi.org/10.3390/ph17081005

Zhou, X., Zhu, Z., Kuang, S., Huang, K., Li, Y., Wang, Y., Chen, H., Hoi, M. P. M., Xu, B., Yang, X., & Zhang, Z. (2024). Tetramethylpyrazine Nitrone (TBN) Reduces Amyloid β Deposition in Alzheimer’s Disease Models by Modulating APP Expression, BACE1 Activity, and Autophagy Pathways. Pharmaceuticals, 17(8), 1005. https://doi.org/10.3390/ph17081005